📰 Reference Product News
Page 2 - Reference Product News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reference Product. Real-time updates on events, politics, business and more.
October 12, 2022
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today released the 9th edition of its Biosimilar Trends Report, which examines the current and future state of the U.S....
August 16, 2022
16.08.2022 - DGAP-News: Formycon AG / Key word(s): Study results/Study Formycons Biosimilar Ustekinumab Candidate FYB202 Shows Comparable Efficacy to Reference Product Stelara* in Phase III Study 16.08.2022 / 07:30 CET/CEST The issuer is solely responsible ... Seite 1
August 7, 2021
On July 28, the FDA approved the country’s first interchangeable biosimilar product. Semglee (insulin glargine-yfgn) is both biosimilar to, and interchangeable with, its reference...
January 18, 2021
Recent legislative developments include amendments to expand upon Orange Book and Purple Book listing requirements. Amidst the breathtaking sweep of activities in the Trump Administration’s waning days in office, the Orange Book Transparency Act of 2020 (the “Orange Book Act”) and the so-called Purple Book Continuing Act (the “Purple Book Act”) were both signed into law with relatively little public fanfare. Both of these bills largely codify in statute the patent-listing and rela...